Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Cotte

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
BMJ Case Reports|May 19, 2012
Fatal cumulative toxicities of HAART in a stable, AIDS-free, HIV-infected patientJulien Saison, Laurent Cotte, Christian Chidiac, et al.
BMC Infectious Diseases|December 21, 2018
Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia - a case reportVincent Alcazer, Patrick Miailhes, Christophe Ramière, et al.
AIDS (London, England)|November 6, 2003
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected menMurielle Mary-Krause, Laurent Cotte, Anne Simon, et al.
Plos Pathogens|September 14, 2021
Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence dataGonché Danesh, Victor Virlogeux, Christophe Ramière, et al.
BMC Public Health|October 15, 2025
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: a single-centre retrospective study at Lyon University Hospital, FranceYanis Merad, Matthieu Godinot, Dulce Alfaiate, et al.
AIDS (London, England)|September 5, 2020
Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis usersCaroline Charre, Vinca Icard, Pierre Pradat, et al.
BMC Infectious Diseases|November 15, 2014
The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort studyLaurent Cotte, Thomas Bénet, Philippe Vanhems, et al.
AIDS (London, England)|June 4, 2008
Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithmsKaren Champenois, Laurence Bocket, Sylvie Deuffic-Burban, et al.
Vaccine|June 22, 2014
Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patientsFlorent Valour, Laurent Cotte, Nicolas Voirin, et al.
The Journal of Infectious Diseases|March 31, 2012
Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escapeNora Martel, Laurent Cotte, Mary-Anne Trabaud, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
BMJ Case Reports|May 19, 2012
Fatal cumulative toxicities of HAART in a stable, AIDS-free, HIV-infected patientJulien Saison, Laurent Cotte, Christian Chidiac, et al.
BMC Infectious Diseases|December 21, 2018
Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia - a case reportVincent Alcazer, Patrick Miailhes, Christophe Ramière, et al.
AIDS (London, England)|November 6, 2003
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected menMurielle Mary-Krause, Laurent Cotte, Anne Simon, et al.
Plos Pathogens|September 14, 2021
Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence dataGonché Danesh, Victor Virlogeux, Christophe Ramière, et al.
BMC Public Health|October 15, 2025
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: a single-centre retrospective study at Lyon University Hospital, FranceYanis Merad, Matthieu Godinot, Dulce Alfaiate, et al.
AIDS (London, England)|September 5, 2020
Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis usersCaroline Charre, Vinca Icard, Pierre Pradat, et al.
BMC Infectious Diseases|November 15, 2014
The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort studyLaurent Cotte, Thomas Bénet, Philippe Vanhems, et al.
AIDS (London, England)|June 4, 2008
Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithmsKaren Champenois, Laurence Bocket, Sylvie Deuffic-Burban, et al.
Vaccine|June 22, 2014
Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patientsFlorent Valour, Laurent Cotte, Nicolas Voirin, et al.
The Journal of Infectious Diseases|March 31, 2012
Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escapeNora Martel, Laurent Cotte, Mary-Anne Trabaud, et al.
Pageof 10